INFORMATICA SYSTEMS LTD: The purpose of the National CKD Audit and Quality Improvement Programme (NCKDA) is to improve the identification and management of CKD in primary care.

Data-sharing agreement from NHS Digital registers of approved data releases, 2014–2019. Evidence status: source reported.

Organisation: INFORMATICA SYSTEMS LTD
Source reference: DARS-NIC-25741-N1H1B-v1.2
Jurisdiction: England
Licence: Open Government Licence v3.0, subject to NHS England terms and exclusions

Register reference: DARS-NIC-25741-N1H1B-v1.2
Agreement period: not published to no end date published
For commercial purposes (as marked in the register): Not stated
Release files listed by NHS England: 17

Data approved

Office for National Statistics Mortality Data (linkable to HES)
Hospital Episode Statistics Admitted Patient Care
Hospital Episode Statistics Critical Care
Hospital Episode Statistics Outpatients
Office for National Statistics Mortality Data

Objective, as published

The purpose of the National CKD Audit and Quality Improvement Programme (NCKDA) is to improve the identification and management of CKD in primary care. The audit will measure variation between practices, as well as clinical commissioning groups (CCGs) and local health boards (LHBs) in Wales, in the identification and management of CKD. Because CKD is a silent disease it is important to test for it. Once a patient is coded for CKD the GP prescribing software will identify this patient as having kidney disease, which may in turn lead to safer prescribing decisions. The audit is designed to address the following objectives: CKD Identification and Recording: • Are patients with risk factors being tested for CKD? (details of patients with risk factors will not be flowed to the HSCIC. The data provided by the HSCIC will not address this question) • Are patients with CKD being correctly diagnosed and given an appropriate CKD Read code? CKD Management: • Are patients with recorded CKD meeting blood pressure targets? • Are patients with recorded CKD having their kidney function monitored regularly? • Are patients with recorded CKD receiving appropriate cardiovascular risk management? • Are patients with CKD being appropriately referred to specialist care? Alongside data on referral patterns specific outcomes to be investigated from linked data will include: • Distribution and number of hospitalisation events via A&E in patients with CKD by CKD-stage within a 6-month period (HES/PEDW)…

Expected benefits, as published

Patient information will be used to improve patient care by improving the diagnosis of chronic kidney disease (CKD) in primary care and to improve diagnosis and care using electronic patient systems. More specifically it will used to: • Deliver the most benefit for patients with CKD and for their practitioners by focusing on CKD stages 3 -5. • Assess local practice against NICE CKD guidelines and NICE CKD quality standards and drive service improvement. • Compare their outcomes of care with similar NHS organisations. • Identify and share best practice. Patient information will be used to serve the wider public interest by identifying gaps or shortfalls in commissioning services and providing a more comprehensive picture of care and outcomes of people with CKD within primary care in Englan…

Source: https://webarchive.nationalarchives.gov.uk/ukgwa/2019/http://content.digital.nhs.uk/media/23167/Data-Release-Register-September---November-2016/xls/Data_Release_Register__September_-_November_2016.xlsx. Captured 2026-10-30.

Limitations: Agreement as recorded in an NHS Digital register of approved data releases (2014–2019), retrieved from the UK Government Web Archive. That register lists releases made in its period and the agreement's purpose statement as it then stood; it gives no agreement dates, and the agreement may have changed since. Imported only where a paper quotes a reference no current register holds.